Bullseye Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bullseye Investment Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,258	Closed	-$1.39M	–	42
2022 Q2	$1.39M	Buy	+10,258	New	+$1.41M	1.25%	18

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Bullseye Investment Management's FBT Position: Q3 2022 in Review

Bullseye Investment Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 10,258 shares — an estimated $1.39M sold.

Bullseye Investment Management first reported a position in FBT in Q2 2022 and held it in 1 quarter. The position peaked at $1.39M in Q2 2022. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

Bullseye Investment Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
Bullseye Investment Management sold 10,258 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $1.39M.
Bullseye Investment Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2022 and held it in 1 quarter.
Bullseye Investment Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.39M in Q2 2022.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Bullseye Investment Management's 13F filing for Q3 2022, filed 12 Oct 2022.